iCompound basics

iCompound provides prices to providers, clinics, and hospitals for hundreds of compounded drugs from 503A and 503B FDA-registered compounding pharmacies. Providers, clinics, and hospitals use iCompound to find the highest quality compounds at the lowest prices.

Simply choose a medical category, enter your zip code, and we’ll show you compounds and pricing from both local and mail order pharmacies. To view the pharmacy information a basic provider verification is required.

Do I have to become a verified provider?

No, you can search our network of products and prices. However, in order to see the associated pharmacy information a basic provider verification process is required. The majority of compounding requires provider verification due to the contracts the pharmacies have with clinics and hospitals.  These contracts do not allow the release of their pricing publicly. We provide an easy verification process that allows you to access all products in our network.

What providers can access pricing?

Doctors, physician assistants and nurse practitioners.

Do you support all medical categories (derm, optho, GI, ENT, dental, weight loss)?

Not at this time. We are actively working to develop relationships with all 503A and 503B pharmacies to provide access to compounds from all medical categories. View the medical categories we do support here.

What is a 503A compounding pharmacy?

503A facilities are referred to by the FDA as a traditional compounding pharmacy that compounds in accordance to patient specific prescriptions and is required by the state boards of pharmacy to comply with USP and guidelines. In this business model, the facility is prohibited from dispensing for office use which limits the product line to items that the patient can use in their home. In addition, the facility may not compound large batches which can lead to increased product cost. A solution to the presented limitations was to add the ability to create exemptions for a compounding pharmacy as a 503B.

What is a 503B compounding pharmacy?

503B facilities are referred to by the FDA as an outsourcing facility that may produce large batches with or without prescriptions. In this model, pharmacies are able to produce larger scale batches to drive down production cost to provide affordable medication to the consumer. Although not required to provide patient specific medications, the facility is then held to a higher standard as a manufacturer requiring full current good manufacturing practice (CGMP) compliance. The FDA has released several draft and final guidance to assist compounding pharmacies in navigating the new outsourcing facility space, however many guidelines remain unclear as apparent in the recent FDA 483 observations and warning letters.

503A vs 503B

A prime difference between 503B and 503A facilities, and a major component of CGMP, is the requirement for every process to be validated in a 503B facility. Before any new product can be brought to market, multiple batches must be made and submitted for testing and stability studies. While this may result in a longer lead time to getting new products to customers, this ensures that every batch made during normal production is consistent in quality and meets the high standards set by the FDA and CGMP. Not only must products be validated, but testing methods must also be validated to ensure accuracy and precision, in accordance to USP standards. All vendors that supply raw materials must be thoroughly vetted, and on-site inspections are performed by the Quality Assurance team for all critical suppliers